The best-protected melanoma cell lines were 451LU, followed by MaMel51 cells, with an increase in viability for BRAF-/MEK-inhibitor-treated samples of 42% and 35% respectively compared to cultures without neutrophils (Figure 2B left, Table 4). The gene discussed is MAP2K7; the disease is melanoma.